{"name": "ChemoCentryx",
 "permalink": "chemocentryx",
 "crunchbase_url": "http://www.crunchbase.com/company/chemocentryx",
 "homepage_url": "http://www.chemocentryx.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1997,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "1-650-210-2900",
 "description": "ChemoKine therapuetics development",
 "created_at": "Fri Jul 24 03:57:29 UTC 2009",
 "updated_at": "Sat Dec 29 12:56:59 UTC 2012",
 "overview": "\u003Cp\u003EChemoCentryx focuses on discovery, development and commercialization of orally-administered small molecule therapeutics that target chemokine receptors and related chemo-attractant receptors. \nTheir small molecule product candidates is designed to target a specific chemokine or chemo-attractant receptor, thereby blocking the inappropriate immune system cascade underlying a given disease.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[127,
       77],
      "assets/images/resized/0005/4088/54088v1-max-150x150.jpg"],
     [[127,
       77],
      "assets/images/resized/0005/4088/54088v1-max-250x250.jpg"],
     [[127,
       77],
      "assets/images/resized/0005/4088/54088v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President, Chief Executive Officer and Chairman of the Board",
    "person":
     {"first_name": "Thomas",
      "last_name": "J. Schall",
      "permalink": "thomas-j-schall",
      "image": null}},
   {"is_past": false,
    "title": "Chief Business Officer and Treasurer",
    "person":
     {"first_name": "Markus",
      "last_name": "J. Cappel",
      "permalink": "markus-j-cappel",
      "image": null}},
   {"is_past": false,
    "title": "Senior Vice President, Finance, Chief Financial Officer and Secretary",
    "person":
     {"first_name": "Susan",
      "last_name": "M. Kanaya",
      "permalink": "susan-m-kanaya",
      "image": null}},
   {"is_past": false,
    "title": "",
    "person":
     {"first_name": "Peter",
      "last_name": "Svennilson",
      "permalink": "peter-svennilson",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$80.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.chemocentryx.com/news/2004/pr20040617.pdf",
    "source_description": "ChemoCentryx Raises $33 Million in Private Financing",
    "raised_amount": 33000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2004,
    "funded_month": 6,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gimv",
         "permalink": "gimv",
         "image":
          {"available_sizes":
            [[[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-150x150.jpg"],
             [[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-250x250.jpg"],
             [[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://deals.venturebeat.com/2007/03/22/chemocentryx-autoimmune-disease-drug-co-raises-2984m/",
    "source_description": "ChemoCentryx, autoimmune disease drug co., raises $29.84M",
    "raised_amount": 29840000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 3,
    "funded_day": 22,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gimv",
         "permalink": "gimv",
         "image":
          {"available_sizes":
            [[[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-150x150.jpg"],
             [[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-250x250.jpg"],
             [[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Glaxo Group",
         "permalink": "glaxo-group",
         "image": null},
       "financial_org": null,
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://chemocentryx.com/news/2006/pr20060824b.html",
    "source_description": "ChemoCentryx Completes Series C Financing",
    "raised_amount": 17700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 8,
    "funded_day": 24,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Jennison Associates",
         "permalink": "jennison-associates",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0008/4571/84571v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0008/4571/84571v1-max-250x250.jpg"],
             [[393,
               55],
              "assets/images/resized/0008/4571/84571v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Techne Corporation",
         "permalink": "techne-corporation",
         "image":
          {"available_sizes":
            [[[150,
               12],
              "assets/images/resized/0008/4572/84572v1-max-150x150.jpg"],
             [[250,
               20],
              "assets/images/resized/0008/4572/84572v1-max-250x250.jpg"],
             [[397,
               33],
              "assets/images/resized/0008/4572/84572v1-max-450x450.jpg"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Gimv",
         "permalink": "gimv",
         "image":
          {"available_sizes":
            [[[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-150x150.jpg"],
             [[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-250x250.jpg"],
             [[65,
               90],
              "assets/images/resized/0004/8587/48587v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "850 Maude Avenue",
    "address2": "",
    "zip_code": "94043",
    "city": "Mountain View",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.397153,
    "longitude": -122.049}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        115],
       "assets/images/resized/0005/4089/54089v1-max-150x150.jpg"],
      [[250,
        193],
       "assets/images/resized/0005/4089/54089v1-max-250x250.jpg"],
      [[450,
        347],
       "assets/images/resized/0005/4089/54089v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}